DEF 14A

Company

Hepion Pharmaceuticals, Inc.

Filed

November 29, 2018

Period of Report

January 15, 2019

Accession Number

0001104659-18-070593

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →